Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.

Employees - 149, CEO - Grigorios Siokas, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): -2.64, Piotroski Score(max is 10): 3, Working Capital: $2812487, Total Assets: $62369011, Retained Earnings: $-135972696, EBIT: -18084664, Total Liabilities: $42542652, Revenue: $69487179

- Current Price $ - Analyst Target Price $